Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s disease

28 Oct 2019

Abstract excerpt

Alzheimer's disease (AD) is characterized by a progressive loss of neurons and cognitive functions. Therefore, early diagnosis of AD is critical. The development of practical and non-invasive diagnostic tests for AD remains, however, an unmet need. In the present proof-of-concept study we investigated tear fluid as a novel source of disease-specific protein and microRNA-based biomarkers for AD development using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Glycation End Products research
Share to Ocular Surface and Contact Lens
Share to Salivary Gland Disorders and Functions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31659197
DOI: 10.1038/s41598-019-51837-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s diseasePMID 31659197Read ↗

MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s diseaseSemantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolitesSemantic proximity Read ↗

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in DementiaSemantic proximity Read ↗

Novel exosome biomarker candidates for Alzheimer´s disease unraveled through Mass Spectrometry analysisSemantic proximity Read ↗

MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.Semantic proximity Read ↗

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature reviewSemantic proximity Read ↗

Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later lifeSemantic proximity Read ↗

Assess Alzheimer’s Disease via Plasma Extracellular Vesicle-derived mRNASemantic proximity Read ↗

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s diseaseSemantic proximity Read ↗

Serum proteomics reveals early biomarkers of Alzheimer's disease: The dual role of APOE-ε4Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.